ALNAJASHI, Hind. Rituximab as an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review. Journal of Contemporary Medical Sciences, [S. l.], v. 11, n. 3, 2025. DOI: 10.22317/jcms.v11i3.1892. Disponível em: https://jocms.org/index.php/jcms/article/view/1892. Acesso em: 19 may. 2026.